Search research articles
Contact Us
Filters
Showing results (901-910 of 953) with videos related to
Page
of 96
Sort By:
Seminars in Arthritis and Rheumatism
|
July 9, 2019
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis
Kim Lauper, Denis Mongin, Florenzo Iannone, et al.
International Journal of Molecular Sciences
|
May 14, 2025
GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated <i>EZH2</i> and <i>TP53</i> at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses
Tal Shahar Gabay, Nofar Stolero, Niv Rabhun, et al.
Hepatology Communications
|
November 23, 2025
Interleukin-18 binding protein protects against metabolic steatohepatitis
Emmanuel Somm, Yunju Jo, Elodie Perroud, et al.
Journal of Crohn'S & Colitis
|
December 14, 2021
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
American Heart Journal
|
December 9, 2003
Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase
Daniel H Berrocal, Mauricio G Cohen, Alejandro D Spinetta, et al.
European Journal of Immunology
|
March 8, 2018
Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection
Katy A Lloyd, Johanna Steen, Khaled Amara, et al.
Annals of the Rheumatic Diseases
|
September 17, 2015
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study
Cem Gabay, Myriam Riek, Merete Lund Hetland, et al.
The Journal of Rheumatology
|
January 17, 2017
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration
Katerina Chatzidionysiou, Elisabeth Lie, Galina Lukina, et al.
Frontiers in Oncology
|
July 12, 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
Yani Berckmans, Hila M Ene, Kerem Ben-Meir, et al.
Plos One
|
December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting
Francesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Page
of 96
Search research articles
Search
Showing results (901-910 of 953) with videos related to
Sort By:
Page
of 96
Seminars in Arthritis and Rheumatism
|
July 9, 2019
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis
Kim Lauper, Denis Mongin, Florenzo Iannone, et al.
International Journal of Molecular Sciences
|
May 14, 2025
GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated <i>EZH2</i> and <i>TP53</i> at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses
Tal Shahar Gabay, Nofar Stolero, Niv Rabhun, et al.
Hepatology Communications
|
November 23, 2025
Interleukin-18 binding protein protects against metabolic steatohepatitis
Emmanuel Somm, Yunju Jo, Elodie Perroud, et al.
Journal of Crohn'S & Colitis
|
December 14, 2021
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
American Heart Journal
|
December 9, 2003
Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase
Daniel H Berrocal, Mauricio G Cohen, Alejandro D Spinetta, et al.
European Journal of Immunology
|
March 8, 2018
Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection
Katy A Lloyd, Johanna Steen, Khaled Amara, et al.
Annals of the Rheumatic Diseases
|
September 17, 2015
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study
Cem Gabay, Myriam Riek, Merete Lund Hetland, et al.
The Journal of Rheumatology
|
January 17, 2017
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration
Katerina Chatzidionysiou, Elisabeth Lie, Galina Lukina, et al.
Frontiers in Oncology
|
July 12, 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
Yani Berckmans, Hila M Ene, Kerem Ben-Meir, et al.
Plos One
|
December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting
Francesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Page
of 96